Symbol	Last Trade	High	Low	Open	Prev Close	Change
ROSG	1.25	1.26	1.23	1.26	1.25	0.00%
Rosetta Genomics				Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010 Israeli HMO to reimburse patients for miRview cancer test Rosetta Genomics to Present at Leerink Swan?s Life Science Tools and Diagnostics Roundtable Conference Rosetta Genomics Names Genekor S.A Exclusive Distributor for Three microRNA-based Assays in Greece Rosetta Genomics Ltd. Names Genekor S.A Exclusive Distributor For Three microRNA-based Assays In Greece
IVGN	24.76	N/A	N/A	N/A	24.76	0.00%
Invitrogen Corpor				Fisher to be honored at gala on Sept. 25 Life Technologies to Present at the UBS Global Life Sciences Conference Trading Alert for Life Technologies Corporation (LIFE) Jatropha genome sequenced Earnings Postmortem for Life Technologies; LIFE, AMGN, BIIB, HGSI
QGEN	18.81	18.82	18.555	18.71	18.44	+2.01%
Qiagen N.v.				Benzinga's Top Pre-Market NASDAQ Gainers (TTWO, FNSR, ULTA, QGEN) Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Sequenom (SQNM, WX, PKI, QGEN, TMO) QIAGEN Launches New Automated Modular Testing Platform for Molecular Diagnostics Top 10 Mid-Cap Stocks with Most Analyst Upgrades: NGD, KLAC, ATK, QGEN, FDO, CAE, CPT, MGA, GNW, PWE (Aug 31, 2010) Sequenom is Among the Companies in the Life Sciences Tools & Services Industry With the Best Relative Performance (SQNM, WX, QGEN, PRXL, CVD)
ABI	12.10	12.10	11.99	12.10	12.10	0.00%
Safety First Trus				ABI inquiry completed in fatal Dothan police shooting Enterprise to rent electric car Digital television going mobile: New mobile high-definition television standard could unleash more gadgets for watching TV on the go Geneva Sheriff's to get computerized finger printing machine
AFFX	Inc."	4.47	4.54	3.75	4.46	4.39
Affymetrix				Bullish movements at NASDAQ: (ABAT, BANR, NTWK, AFFX, AKRX) Daily Options Trading for Affymetrix (AFFX) Shares of Cambrex Rank the Highest in terms of Cash Flow in the Life Sciences Tools & Services Industry (CBM, AFFX, CCEL, HBIO, PKI) NASDAQ corrections in focus: (GNBT, RPRX, AFFX, ENTG, AVNR) The Life Sciences Tools & Services Industry Top Value Investment is Kendle International (KNDL, CBM, BDSI, PRXL, AFFX)
ILMN	Inc."	44.61	45.00	25.59	44.90	44.76
Illumina				Charles River Laboratories has the Best Relative Performance in the Life Sciences Tools & Services Industry (CRL, PPDI, ILMN, WX, WAT) Critical Movement for Illumina (ILMN) TOP 5 COMPANIES IN THE LIFE SCIENCES TOOLS SERVICES INDUSTRY WITH THE HIGHEST LEVEL OF EFFICIENCY (BDSI, ILMN, TECH, LIFE, CCEL) After Yesterday's Rally of 2.33%, Illumina Shares Could Pullback (ILMN) Astrid Research Launches Bioinformatics Solution For Next-Generation Sequencing Data
SQNM	Inc."	6.20	6.28	2.55	6.22	6.19
Sequenom				Sequenom near Key Resistance Area Sequenom to Present at Two Financial Conferences in September Relatively Low Performance Detected in Shares of Accuray in the Healthcare Sector (ARAY, NTY, GENZ, CHBT, SQNM) Trading Idea - Sequenom Broke Resistance, What to Expect? Money Flow Negative for Sequenom Inc.; SQNM
CPHD	17.40	17.65	17.11	17.42	17.27	+0.75%
Cepheid				Shares of Cepheid Rank the Highest in terms of Relative Performance in the Biotechnology Industry (CPHD, REGN, DNDN, ITMN, SGEN) J--CEPHEID SERVICE CONTRACT - BASE FY11 New England Journal of Medicine Study Reports Xpert MTB/RIF a Faster, More Sensitive & Specific Test for Tuberculosis (TB) Than Current World Standards Cepheid to Webcast Upcoming Financial Presentations Cepheid Stays Neutral
A	29.85	29.99	29.49	29.49	29.21	+2.19%
Agilent Technolog				Reduce Cost Per Sample with New Sample Prep Workbench from Agilent Agilent Technologies has the Best Relative Performance in the Electronic Equipment & Instruments Industry (A, CSR, ITRI, FLIR, ID) Shares of Agilent Technologies (A) May Continue to Rise TRADE NEWS: Agilent Technologies Ships 300th X-Ray Crystallography System Agilent Technologies to launch new sample preparation tool
LMNX	15.17	15.23	14.87	15.17	14.90	+1.81%
Luminex Corporati				A Post-Earnings Checkup on Insulet; PODD, ACL, LMNX, ICUI Top 5 Companies in the Life Sciences Tools & Services Industry With the Highest Short Interest (LMNX, CALP, PURE, SQNM, ILMN) Luminex Announces Commercial Launch of New Cystic Fibrosis Test Luminex Corporation Announces Commercial Launch of New Cystic Fibrosis Test Luminex makes Fortune 'fastest-growing'
MIL	0.00	N/A	N/A	N/A	N/A	N/A
Mil				Bruker taps Charles Wagner for board Millipore Corporation Reminds Holders of Its 3.75% Convertible Senior Notes That Make-Whole Conversion Period Expires August 25, 2010 Bruker Corporation Elects Charles Wagner as Independent Director Luminex Launches New MAGPIX Multiplexing Instrument Millipore Reports Change of Control and Right of Holders to Require Purchase of Its 5.875 percent Senior Notes
SIAL	55.58	55.95	55.21	55.70	55.17	+0.74%
Sigma-aldrich Cor				ILM Features Editor, Tamsyn Cox, spoke to Martin Sylt Is Sigma-Aldrich Growing or Slowing? Sigma® Life Science Enters Genetically Modified Cell Market Shares of Sigma-Aldrich Corporation (SIAL) May Continue to Rise Best Relative Performance in the Specialty Chemicals Industry Detected in Shares of Ferro (FOE, POL, LZ, SIAL, ECL)
ALNY	14.81	14.98	14.6501	14.98	14.81	0.00%
Alnylam Pharmaceu				Technology of the Week: An alternative to chemotherapy Market Reaction to Earnings from InterMune; ITMN, AMGN, ALNY, TRGT Alnylam Begins Phase I Drug Trials of ALN-VSP SmarTrend's Candlestick Scanner Detects Possible Bullish Engulfing Pattern for Alnylam Pharmaceuticals (ALNY) Post Earnings Update: Alnylam Pharmaceuticals Has Trended 8.84% Lower In Past 16 Days (ALNY)
ISIS	8.20	8.23	8.05	8.20	8.12	+0.99%
Isis Pharmaceutic				Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC Genzyme Corporation And Isis Pharmaceuticals Announce Data From Mipomersen Phase 3 Trial In heFH Patients Presented; Study Meets Primary Endpoint With 28% LDL-C Reduction Isis Pharmaceuticals Sets Date for Webcast to Discuss Mipomersen Data Presented at the ESC Congress 2010 Genzyme Rejects Sanofi Offer Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
INDEX	197.93	229.49	226.9751	204.92	251.61	+8.49%
*Stock quotes are delayed 20 min